What's new

Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 25, Status: Authorised

Feb 18, 2025 - 16:58
 0
Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

J&J resumes PFA cases, but analysts warn safety may hamper rollout

Next Article

Wholesale platform Joor aims to reshape retail partnerships

Related Posts

Orphan designation: Synthetic double-stranded siRNA oligonucleotide directed against apolipoprotein C-III mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues Treatment of familial chylomicronaemia syndrome, 19/07/2021 Positive

Orphan designation: Synthetic double-stranded siRNA oli...

Feb 24, 2025  0

New Approach Methodologies EU-IN Horizon Scanning Report

Feb 24, 2025  0

DARWIN EU data partners onboarded in phases I, II and III

Feb 20, 2025  0